Hazel Hunt - 08 Jan 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Scientific Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Hazel Hunt
Issuer symbol
CORT
Transactions as of
08 Jan 2024
Net transactions value
-$667,088
Form type
4
Filing time
12 Jan 2024, 20:06:56 UTC
Previous filing
15 Aug 2023
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $151,000 +50,000 +68% $3.02* 123,146 08 Jan 2024 Direct
transaction CORT Common Stock Tax liability $818,088 -29,792 -24% $27.46 93,354 08 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (right to buy) Options Exercise $0 -50,000 -100% $0.000000* 0 08 Jan 2024 Common Stock 50,000 $3.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 6, 2024.
F2 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.